<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"	
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/"
	>
<channel>
	<title>Ob/Gyn &#187; The Doctor&#039;s Channel</title>
	<atom:link href="http://www.thedoctorschannel.com/channels/obgyn/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thedoctorschannel.com</link>
	<description>Internet TV for Doctors</description>
	<lastBuildDate>Wed, 16 May 2012 23:34:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
			<item>
		<title>Mefloquine malaria prophylaxis appears safe during pregnancy</title>
		<link>http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/</link>
		<pubDate>Mon, 14 May 2012 17:09:43 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Travel Medicine]]></category>
		<category><![CDATA[malaria]]></category>
		<category><![CDATA[Mefloquine]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31746</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></description>
		
			<media:content duration="1:47" medium="video">
		<media:title><![CDATA[Mefloquine malaria prophylaxis appears safe during pregnancy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Pregnant women may safely receive mefloquine for malaria prophylaxis, researchers from Switzerland report in the April 10th online Clinical Infectious Diseases. “Women who inadvertently become pregnant while taking mefloquine should be reassured that the risk of malformations is low (within background levels) and that use of mefloquine does not indicate -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/mefloquine-malaria-prophylaxis-appears-safe-during-pregnancy-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120514epid0011.jpg"/>
	<media:keywords><![CDATA[malaria,Mefloquine,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Postpartum implants curb adolescent pregnancies</title>
		<link>http://www.thedoctorschannel.com/view/postpartum-implants-curb-adolescent-pregnancies/</link>
		<pubDate>Fri, 11 May 2012 20:50:26 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[contraceptive]]></category>
		<category><![CDATA[etonogestrel]]></category>
		<category><![CDATA[Teen pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=31699</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; Giving adolescent mothers postpartum contraceptive implants is an effective curb on further pregnancies within a year, researchers report in an April 18th on-line paper in the American Journal of Obstetrics and Gynecology.&#8221; &#8220;Initiation of the etonogestrel implant immediately after delivery,&#8221; Dr. Kristina M. Tocce, told Reuters Health by email &#8220;significantly -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Postpartum implants curb adolescent pregnancies]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; Giving adolescent mothers postpartum contraceptive implants is an effective curb on further pregnancies within a year, researchers report in an April 18th on-line paper in the American Journal of Obstetrics and Gynecology.&#8221; &#8220;Initiation of the etonogestrel implant immediately after delivery,&#8221; Dr. Kristina M. Tocce, told Reuters Health by email &#8220;significantly -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/postpartum-implants-curb-adolescent-pregnancies/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/05/Thumbnail_20120511clin004.jpg"/>
	<media:keywords><![CDATA[contraceptive,etonogestrel,Teen pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Substantial Increase in Pregnant Women Using Opiates and Newborns with Drug Withdrawal Syndrome in the US</title>
		<link>http://www.thedoctorschannel.com/view/substantial-increase-in-pregnant-women-using-opiates-and-newborns-with-drug-withdrawal-syndrome-in-the-us/</link>
		<pubDate>Mon, 07 May 2012 16:00:33 +0000</pubDate> 
				<category><![CDATA[Featured]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[The JAMA Report]]></category>
		<category><![CDATA[death]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[opiate pain]]></category>
		<category><![CDATA[opioids]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[pregnancy]]></category>
		<category><![CDATA[pregnant]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[teenagers]]></category>
		<category><![CDATA[teens]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30862</guid>
		<description><![CDATA[Recent studies show that sales and deaths related to opiate pain relievers have quadrupled over the last decade in the United States. Also, illicit drug use among pregnant teens is just over 16 percent. A new study examined just how many pregnant women are using these drugs at the time of delivery and the number -]]></description>
		
			<media:content duration="1:39" medium="video">
		<media:title><![CDATA[Substantial Increase in Pregnant Women Using Opiates and Newborns with Drug Withdrawal Syndrome in the US]]></media:title>
	<media:description><![CDATA[Recent studies show that sales and deaths related to opiate pain relievers have quadrupled over the last decade in the United States. Also, illicit drug use among pregnant teens is just over 16 percent. A new study examined just how many pregnant women are using these drugs at the time of delivery and the number -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/substantial-increase-in-pregnant-women-using-opiates-and-newborns-with-drug-withdrawal-syndrome-in-the-us/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Picture-10.png"/>
	<media:keywords><![CDATA[death,drugs,opiate pain,opioids,pain,pregnancy,pregnant,sales,teenagers,teens,The JAMA Report]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Benzodiazepine use safe during lactation</title>
		<link>http://www.thedoctorschannel.com/view/benzodiazepine-use-safe-during-lactation/</link>
		<pubDate>Fri, 27 Apr 2012 19:13:04 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Pharmacists]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[benzodiazepine]]></category>
		<category><![CDATA[breast feeding]]></category>
		<category><![CDATA[lactation]]></category>
		<category><![CDATA[nursing]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30284</guid>
		<description><![CDATA[NEW YORK (Reuters Health) &#8211; The sedative effects of benzodiazepine exposure through breast milk appear to present minimal risk of central nervous system (CNS) depression in infants, results of a new study suggest. Currently, breastfeeding is not contraindicated in women using psychotropic medications such as benzodiazepines. Dr. Gideon Koren from the Hospital for Sick Children, -]]></description>
		
			<media:content duration="1:35" medium="video">
		<media:title><![CDATA[Benzodiazepine use safe during lactation]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) &#8211; The sedative effects of benzodiazepine exposure through breast milk appear to present minimal risk of central nervous system (CNS) depression in infants, results of a new study suggest. Currently, breastfeeding is not contraindicated in women using psychotropic medications such as benzodiazepines. Dr. Gideon Koren from the Hospital for Sick Children, -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/benzodiazepine-use-safe-during-lactation/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120427clin003.jpg"/>
	<media:keywords><![CDATA[benzodiazepine,breast feeding,lactation,nursing]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Antenatal steroids no benefit in late preterm neonates</title>
		<link>http://www.thedoctorschannel.com/view/antenatal-steroids-no-benefit-in-late-preterm-neonates-2/</link>
		<pubDate>Wed, 25 Apr 2012 22:02:19 +0000</pubDate> 
				<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[antenatal steroids]]></category>
		<category><![CDATA[late-preterm]]></category>
		<category><![CDATA[lung]]></category>
		<category><![CDATA[respiratory]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30213</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – When testing indicates fetal lung immaturity at 34 weeks’ gestation or more, administration of antenatal corticosteroids does not reduce respiratory problems in the newborn, and the better approach is expectant management to prolong gestation as long as possible. “Not only does steroid administration appear to have no benefit when administered -]]></description>
		
			<media:content duration="1:43" medium="video">
		<media:title><![CDATA[Antenatal steroids no benefit in late preterm neonates]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – When testing indicates fetal lung immaturity at 34 weeks’ gestation or more, administration of antenatal corticosteroids does not reduce respiratory problems in the newborn, and the better approach is expectant management to prolong gestation as long as possible. “Not only does steroid administration appear to have no benefit when administered -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/antenatal-steroids-no-benefit-in-late-preterm-neonates-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120425clin013.jpg"/>
	<media:keywords><![CDATA[antenatal steroids,late-preterm,lung,respiratory]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Add-on bevacizumab slows progression of recurrent ovarian cancer</title>
		<link>http://www.thedoctorschannel.com/view/add-on-bevacizumab-slows-progression-of-recurrent-ovarian-cancer-2/</link>
		<pubDate>Wed, 25 Apr 2012 21:43:45 +0000</pubDate> 
				<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[Bevacizumab]]></category>
		<category><![CDATA[carboplatin ovarian cancer]]></category>
		<category><![CDATA[gemcitabine]]></category>
		<category><![CDATA[OCEANS trial]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=30200</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in the Journal of Clinical Oncology online April 23. “As ovarian cancer becomes a chronic illness, treatments that prolong PFS, and therefore time without cytotoxic chemotherapy, become increasingly -]]></description>
		
			<media:content duration="1:18" medium="video">
		<media:title><![CDATA[Add-on bevacizumab slows progression of recurrent ovarian cancer]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Progression-free survival (PFS) is significantly longer in women with recurrent ovarian cancer when bevacizumab is added to chemotherapy, a multicenter team reports in the Journal of Clinical Oncology online April 23. “As ovarian cancer becomes a chronic illness, treatments that prolong PFS, and therefore time without cytotoxic chemotherapy, become increasingly -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/add-on-bevacizumab-slows-progression-of-recurrent-ovarian-cancer-2/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120425drgd005.jpg"/>
	<media:keywords><![CDATA[Bevacizumab,carboplatin ovarian cancer,gemcitabine,OCEANS trial]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Nomegestrol-estradiol OC effective with good cycle control</title>
		<link>http://www.thedoctorschannel.com/view/nomegestrol-estradiol-oc-effective-with-good-cycle-control/</link>
		<pubDate>Wed, 25 Apr 2012 00:50:52 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Pediatrics]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[contraceptive]]></category>
		<category><![CDATA[Nomegestrol estradiol]]></category>
		<category><![CDATA[Zoely]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28590</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than an OC containing drospirenone and ethinyl E2 in a 21–7-day regimen, investigators report in the May issue of Obstetrics &#038; Gynecology. “The high contraceptive efficacy of nomegestrol -]]></description>
		
			<media:content duration="1:42" medium="video">
		<media:title><![CDATA[Nomegestrol-estradiol OC effective with good cycle control]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – A combined oral contraceptive containing nomegestrol acetate and 17beta-estradiol (E2) taken in a 24–4-day regimen is somewhat more effective in preventing pregnancy than an OC containing drospirenone and ethinyl E2 in a 21–7-day regimen, investigators report in the May issue of Obstetrics &#038; Gynecology. “The high contraceptive efficacy of nomegestrol -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/nomegestrol-estradiol-oc-effective-with-good-cycle-control/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120424drgd013.jpg"/>
	<media:keywords><![CDATA[contraceptive,Nomegestrol estradiol,Zoely]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Risk of small bowel obstruction less with laparoscopic than open surgery</title>
		<link>http://www.thedoctorschannel.com/view/risk-of-small-bowel-obstruction-less-with-laparoscopic-than-open-surgery/</link>
		<pubDate>Fri, 20 Apr 2012 21:37:40 +0000</pubDate> 
				<category><![CDATA[Gastroenterology]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Surgery]]></category>
		<category><![CDATA[appendectomy]]></category>
		<category><![CDATA[Bariatric Surgery]]></category>
		<category><![CDATA[bowel resection]]></category>
		<category><![CDATA[cholecystectomy]]></category>
		<category><![CDATA[hysterectomy]]></category>
		<category><![CDATA[laparoscopy]]></category>
		<category><![CDATA[rectal resection]]></category>
		<category><![CDATA[rectopexy]]></category>
		<category><![CDATA[salpingo-oophorectomy]]></category>
		<category><![CDATA[SBO]]></category>
		<category><![CDATA[small bowel obstruction]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28402</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – The likelihood of small bowel obstruction (SBO) developing because of adhesions following abdominal or pelvic surgery is generally lower with laparoscopic procedures than with open operations, a Swedish team reports in the April issue of the Archives of Surgery. “This study shows that, beyond important factors such as age, previous -]]></description>
		
			<media:content duration="1:37" medium="video">
		<media:title><![CDATA[Risk of small bowel obstruction less with laparoscopic than open surgery]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – The likelihood of small bowel obstruction (SBO) developing because of adhesions following abdominal or pelvic surgery is generally lower with laparoscopic procedures than with open operations, a Swedish team reports in the April issue of the Archives of Surgery. “This study shows that, beyond important factors such as age, previous -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/risk-of-small-bowel-obstruction-less-with-laparoscopic-than-open-surgery/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120420clin003.jpg"/>
	<media:keywords><![CDATA[appendectomy,Bariatric Surgery,bowel resection,cholecystectomy,hysterectomy,laparoscopy,rectal resection,rectopexy,salpingo-oophorectomy,SBO,small bowel obstruction]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Age over 30 not a risk factor for hypothyroidism in pregnancy</title>
		<link>http://www.thedoctorschannel.com/view/age-over-30-not-a-risk-factor-for-hypothyroidism-in-pregnancy/</link>
		<pubDate>Wed, 18 Apr 2012 20:58:48 +0000</pubDate> 
				<category><![CDATA[Family Medicine]]></category>
		<category><![CDATA[Internal Medicine]]></category>
		<category><![CDATA[Nurses/NP/PA]]></category>
		<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[Women’s Health]]></category>
		<category><![CDATA[hypothyroidism]]></category>
		<category><![CDATA[pregnancy]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=28338</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Women older than age 30 are no more likely than younger women to develop hypothyroidism in pregnancy, suggest results a study from the Czech Republic. Current (2011) guidelines from the American Thyroid Association include age over 30 as one of the risk factors for hypothyroidism in pregnancy. To verify whether -]]></description>
		
			<media:content duration="1:36" medium="video">
		<media:title><![CDATA[Age over 30 not a risk factor for hypothyroidism in pregnancy]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Women older than age 30 are no more likely than younger women to develop hypothyroidism in pregnancy, suggest results a study from the Czech Republic. Current (2011) guidelines from the American Thyroid Association include age over 30 as one of the risk factors for hypothyroidism in pregnancy. To verify whether -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/age-over-30-not-a-risk-factor-for-hypothyroidism-in-pregnancy/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120418epid002.jpg"/>
	<media:keywords><![CDATA[hypothyroidism,pregnancy]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
			<item>
		<title>Less pain during hysterosalpingography with warm contrast medium</title>
		<link>http://www.thedoctorschannel.com/view/less-pain-during-hysterosalpingography-with-warm-contrast-medium/</link>
		<pubDate>Wed, 11 Apr 2012 02:24:22 +0000</pubDate> 
				<category><![CDATA[Ob/Gyn]]></category>
		<category><![CDATA[Radiology]]></category>
		<category><![CDATA[Reuters Health • The Doctor's Channel Daily Newscast]]></category>
		<category><![CDATA[contrast]]></category>
		<category><![CDATA[HSG]]></category>
		<category><![CDATA[hysterosalpingography]]></category>
		<guid isPermaLink="false">http://www.thedoctorschannel.com/?p=27918</guid>
		<description><![CDATA[NEW YORK (Reuters Health) – Warming contrast medium from room temperature to body temperature reduces pain experienced during hysterosalpingography and the occurrence of vasovagal episodes, according to the results of a prospective randomized trial conducted in China. “Compared with the warm medium, room-temperature medium is a cold irritation to body. Cold irritation can convert into -]]></description>
		
			<media:content duration="1:25" medium="video">
		<media:title><![CDATA[Less pain during hysterosalpingography with warm contrast medium]]></media:title>
	<media:description><![CDATA[NEW YORK (Reuters Health) – Warming contrast medium from room temperature to body temperature reduces pain experienced during hysterosalpingography and the occurrence of vasovagal episodes, according to the results of a prospective randomized trial conducted in China. “Compared with the warm medium, room-temperature medium is a cold irritation to body. Cold irritation can convert into -]]></media:description>
	<media:player url="http://www.thedoctorschannel.com/view/less-pain-during-hysterosalpingography-with-warm-contrast-medium/" />
		<media:thumbnail url= "http://www.thedoctorschannel.com/wp-content/uploads/2012/04/Thumbnail_20120410clin002.jpg"/>
	<media:keywords><![CDATA[contrast,HSG,hysterosalpingography]]></media:keywords>
<media:copyright>The Doctor's Channel</media:copyright>
	</media:content>
			</item>
	</channel>
</rss>
